相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Astragaloside IV suppresses inflammatory response via suppression of NF-κB, and MAPK signalling in human bronchial epithelial cells
Hsi-Lung Hsieh et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2022)
Ten Unsolved Questions About Neuroinflammation in Parkinson's Disease
Etienne C. Hirsch et al.
MOVEMENT DISORDERS (2021)
Impaired autophagy in microglia aggravates dopaminergic neurodegeneration by regulating NLRP3 inflammasome activation in experimental models of Parkinson's disease
Yue Qin et al.
BRAIN BEHAVIOR AND IMMUNITY (2021)
Semaglutide attenuates seizure severity and ameliorates cognitive dysfunction by blocking the NLR family pyrin domain containing 3 inflammasome in pentylenetetrazole-kindled mice
Lei Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2021)
Neuroprotective effects of garlic extract on dopaminergic neurons of substantia nigra in a rat model of Parkinson's disease: motor and non-motor outcomes
Maryam Bigham et al.
METABOLIC BRAIN DISEASE (2021)
Reactive astrocyte nomenclature, definitions, and future directions
Carole Escartin et al.
NATURE NEUROSCIENCE (2021)
Anti-Inflammatory Effects of Curcumin in the Inflammatory Diseases: Status, Limitations and Countermeasures
Ying Peng et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2021)
Schisandrol A Suppresses Catabolic Factor Expression by Blocking NF-κB Signaling in Osteoarthritis
Seong Jae Han et al.
PHARMACEUTICALS (2021)
Dysregulation of the Adaptive Immune System in Patients With Early-Stage Parkinson Disease
Zhaoqi Yan et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)
Functional outcomes of an integrated Parkinson's Disease Wellbeing Program
Jeremey T. Horne et al.
AUSTRALASIAN JOURNAL ON AGEING (2020)
Brain aging: A Ianus-faced player between health and neurodegeneration
Silvia Vanni et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2020)
High Fat Diet Suppresses Peroxisome Proliferator-Activated Receptors and Reduces Dopaminergic Neurons in the Substantia Nigra
Yu-Chia Kao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Potential therapeutic effects of antagonizing adenosine A2A receptor, curcumin and niacin in rotenone-induced Parkinson's disease mice model
Tarek K. Motawi et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2020)
NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy
Rachael H. Earls et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Meningeal Immunity and Its Function in Maintenance of the Central Nervous System in Health and Disease
Kalil Alves de Lima et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)
Smelling and Tasting Parkinson's Disease: Using Senses to Improve the Knowledge of the Disease
Valentina Oppo et al.
FRONTIERS IN AGING NEUROSCIENCE (2020)
Cannabidiol in Parkinson's disease
Carlos R. Rieder
BRAZILIAN JOURNAL OF PSYCHIATRY (2020)
Schisandrins impact on the efficiency of human body: A review
K. Leis et al.
SCIENCE & SPORTS (2020)
α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson's disease
Cecilia S. Lindestam Arlehamn et al.
NATURE COMMUNICATIONS (2020)
Microbiota and Other Preventive Strategies and Non-genetic Risk Factors in Parkinson's Disease
Rafael Franco et al.
FRONTIERS IN AGING NEUROSCIENCE (2020)
Peripheral Immunosenescence and Central Neuroinflammation: A Dangerous Liaison - A Dietary Approach
Thea Magrone et al.
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2020)
The role of microglia in the development of neurodegeneration
Aigul R. Saitgareeva et al.
NEUROLOGICAL SCIENCES (2020)
Pro-Resolving Effect of Ginsenosides as an Anti-Inflammatory Mechanism of Panax ginseng
Dong-Soon Im
BIOMOLECULES (2020)
Therapeutic innovation in Parkinson's disease: a 2020 update on disease-modifying approaches
Daniele Colombo et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2020)
Inflammation in Parkinson's Disease: Mechanisms and Therapeutic Implications
Marta Pajares et al.
CELLS (2020)
Neuroinflammatory Responses and Parkinson' Disease: Pathogenic Mechanisms and Therapeutic Targets
Liuna Yang et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2020)
Supplementary management with Pycnogenol® in Parkinson's disease to prevent cognitive impairment
Maria R. Cesarone et al.
JOURNAL OF NEUROSURGICAL SCIENCES (2020)
Acupuncture inhibits neuroinflammation and gut microbial dysbiosis in a mouse model of Parkinson's disease
Jae-Hwan Jang et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Plasma immune markers in an idiopathic REM sleep behavior disorder cohort
Hui Zhang et al.
PARKINSONISM & RELATED DISORDERS (2020)
The role of natural killer cells in Parkinson's disease
Rachael H. Earls et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Chasing Protection in Parkinson's Disease: Does Exercise Reduce Risk and Progression?
Grace F. Crotty et al.
FRONTIERS IN AGING NEUROSCIENCE (2020)
Remodeling microglia to a protective phenotype in Parkinson's disease?
Ifeoluwa Oluleke Awogbindin et al.
NEUROSCIENCE LETTERS (2020)
A Diversity of Cell Types, Subtypes and Phenotypes in the Central Nervous System: The Importance of Studying Their Complex Relationships
Marie-Eve Tremblay
FRONTIERS IN CELLULAR NEUROSCIENCE (2020)
Azathioprine immunosuppression and disease modification in Parkinson's disease (AZA-PD): a randomised double-blind placebo-controlled phase II trial protocol
Julia C. Greenland et al.
BMJ OPEN (2020)
A neuroscience perspective of the gut theory of Parkinson's disease
Lisa M. Smith et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2019)
The risk of Parkinson's disease in inflammatory bowel disease: A systematic review and meta-analysis
Feng Zhu et al.
DIGESTIVE AND LIVER DISEASE (2019)
Emerging therapies in Parkinson disease - repurposed drugs and new approaches
Ahmad Elkouzi et al.
NATURE REVIEWS NEUROLOGY (2019)
Neuroprotection of Fasting Mimicking Diet on MPTP-Induced Parkinson's Disease Mice via Gut Microbiota and Metabolites
Zhi-Lan Zhou et al.
NEUROTHERAPEUTICS (2019)
Do Th17 Lymphocytes and IL-17 Contribute to Parkinson's Disease? A Systematic Review of Available Evidence
Elisa Storelli et al.
FRONTIERS IN NEUROLOGY (2019)
Dietary Vitamin E as a Protective Factor for Parkinson's Disease: Clinical and Experimental Evidence
Tommaso Schirinzi et al.
FRONTIERS IN NEUROLOGY (2019)
Blocking meningeal lymphatic drainage aggravates Parkinson's disease-like pathology in mice overexpressing mutated α-synuclein
Wenyan Zou et al.
TRANSLATIONAL NEURODEGENERATION (2019)
Plasma VCAM1 levels correlate with disease severity in Parkinson's disease
Caroline Perner et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Establishing a framework for neuropathological correlates and glymphatic system functioning in Parkinson's disease
Saranya Sundaram et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2019)
Does Acupuncture Protect Dopamine Neurons in Parkinson's Disease Rodent Model?: A Systematic Review and Meta-Analysis
Jade Heejae Ko et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson's disease
B. R. Bloem et al.
BMC NEUROLOGY (2019)
IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease
Zhan Liu et al.
BRAIN BEHAVIOR AND IMMUNITY (2019)
Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease
Chin-Hsien Lin et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Blood-brain barrier opening with focused ultrasound in experimental models of Parkinson's disease
Maria Eleni Karakatsani et al.
MOVEMENT DISORDERS (2019)
Acupuncture protects from 6-OHDA-induced neuronal damage by balancing the ratio of DMT1/Fpn1
Lihong Li et al.
SAUDI JOURNAL OF BIOLOGICAL SCIENCES (2019)
Tanshinone IIA Exerts Anti-Inflammatory and Immune-Regulating Effects on Vulnerable Atherosclerotic Plaque Partially via the TLR4/MyD88/NF-κB Signal Pathway
Zhuo Chen et al.
FRONTIERS IN PHARMACOLOGY (2019)
Human Gut-Associated Natural Killer Cells in Health and Disease
Alessandro Poggi et al.
FRONTIERS IN IMMUNOLOGY (2019)
Infectious Etiologies of Parkinsonism: Pathomechanisms and Clinical Implications
Nattakarn Limphaibool et al.
FRONTIERS IN NEUROLOGY (2019)
miR-let-7a suppresses α-Synuclein-induced microglia inflammation through targeting STAT3 in Parkinson's disease
Jianzhong Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Niacin Ameliorates Neuro-Inflammation in Parkinson's Disease via GPR109A
Banabihari Giri et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
In vitro Characterization of Gut Microbiota-Derived Bacterial Strains With Neuroprotective Properties
Suaad Ahmed et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson's Disease
R. Lee Mosley et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson's disease
Shirley Yin-Yu Pang et al.
TRANSLATIONAL NEURODEGENERATION (2019)
The effect of dextromethorphan use in Parkinson's disease: A 6-hydroxydopamine rat model and population-based study
Cheng-Tsung Liu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Astragaloside IV ameliorates motor deficits and dopaminergic neuron degeneration via inhibiting neuroinflammation and oxidative stress in a Parkinson's disease mouse model
Cong Yang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's disease
Paraskevi Krashia et al.
NATURE COMMUNICATIONS (2019)
Catalpol Exerts a Neuroprotective Effect in the MPTP Mouse Model of Parkinson's Disease
Li-Yuan Wang et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Catalpol Inhibits Homocysteine-induced Oxidation and Inflammation via Inhibiting Nox4/NF-B and GRP78/PERK Pathways in Human Aorta Endothelial Cells
Huimin Hu et al.
INFLAMMATION (2019)
The neuroprotective effect of schisandrol A on 6-OHDA-induced PD mice may be related to PI3K/AKT and IKK/IκBα/NF-κB pathway
Tingxu Yan et al.
EXPERIMENTAL GERONTOLOGY (2019)
Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer's disease
Baban S. Thawkar et al.
JOURNAL OF NEUROIMMUNOLOGY (2019)
Mediterranean diet adherence is related to reduced probability of prodromal Parkinson's disease
Maria Maraki et al.
MOVEMENT DISORDERS (2019)
Therapeutic targeting of the NRF2 and KEAP 1 partnership in chronic diseases
Antonio Cuadrado et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Intrastriatal injection of preformed alpha-synuclein fibrils alters central and peripheral immune cell profiles in non-transgenic mice
Rachael H. Earls et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments
Yoo Jin Jung et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Diet in Parkinson's Disease: Critical Role for the Microbiome
Aeja Jackson et al.
FRONTIERS IN NEUROLOGY (2019)
A nutritional approach to microbiota in Parkinson's disease
Gizem Ozata Uyar et al.
BIOSCIENCE OF MICROBIOTA FOOD AND HEALTH (2019)
T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease
Javier Campos-Acuna et al.
FRONTIERS IN IMMUNOLOGY (2019)
Parkinson's progression prediction using machine learning and serum cytokines
Diba Ahmadi Rastegar et al.
NPJ PARKINSONS DISEASE (2019)
Lixisenatide reduces amyloid plaques, neurofibrillary tangles and neuroinflammation in an APP/PS1/tau mouse model of Alzheimer's disease
Hong-Yan Cai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Th17 Lymphocytes Induce Neuronal Cell Death in a Human iPSC-Based Model of Parkinson's Disease
Annika Sommer et al.
CELL STEM CELL (2018)
Peripheral monocyte entry is required for alpha-Synuclein induced inflammation and Neurodegeneration in a model of Parkinson disease
Ashley S. Harms et al.
EXPERIMENTAL NEUROLOGY (2018)
Acteoside protects against 6-OHDA-induced dopaminergic neuron damage via Nrf2-ARE signaling pathway
Maiquan Li et al.
FOOD AND CHEMICAL TOXICOLOGY (2018)
Anti-Inflammatory Effects of Resveratrol: Mechanistic Insights
Diego de Sa Coutinho et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Is Curcumin a Possibility to Treat Inflammatory Bowel Diseases?
Rafaela Mazieiro et al.
JOURNAL OF MEDICINAL FOOD (2018)
Niacin modulates macrophage polarization in Parkinson's disease
Chandramohan Wakade et al.
JOURNAL OF NEUROIMMUNOLOGY (2018)
Bidirectional Neural Interaction Between Central Dopaminergic and Gut Lesions in Parkinson's Disease Models
Pablo Garrido-Gil et al.
MOLECULAR NEUROBIOLOGY (2018)
Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson's disease
Seung Pil Yun et al.
NATURE MEDICINE (2018)
Pramipexole and Fingolimod exert neuroprotection in a mouse model of Parkinson's disease by activation of sphingosine kinase 1 and Akt kinase
Joanna Motyl et al.
NEUROPHARMACOLOGY (2018)
Cellular Senescence Is Induced by the Environmental Neurotoxin Paraquat and Contributes to Neuropathology Linked to Parkinson's Disease
Shankar J. Chinta et al.
CELL REPORTS (2018)
Ginsenosides: A Potential Neuroprotective Agent
Mengmeng Zheng et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Anti-Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease
Inga Peter et al.
JAMA NEUROLOGY (2018)
Anti-Parkinson Potential of Silymarin: Mechanistic Insight and Therapeutic Standing
Hammad Ullah et al.
FRONTIERS IN PHARMACOLOGY (2018)
Natural killer cells in inflammation and autoimmunity
Beatrice Zitti et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2018)
Immunomodulatory Roles of PACAP and VIP: Lessons from Knockout Mice
Catalina Abad et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2018)
Fingolimod (FTY720) is not protective in the subacute MPTP mouse model of Parkinson's disease and does not lead to a sustainable increase of brain-derived neurotrophic factor
Daniel Komnig et al.
JOURNAL OF NEUROCHEMISTRY (2018)
Vitamin D protects dopaminergic neurons against neuroinflammation and oxidative stress in hemiparkinsonian rats
Ludmila A. R. Lima et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Occupational Stress and Risk for Parkinson's Disease: A Nationwide Cohort Study
Johanna Sieurin et al.
MOVEMENT DISORDERS (2018)
A randomized, controlled pilot study of the effects of vitamin D supplementation on balance in Parkinson's disease: Does age matter?
Amie L. Hiller et al.
PLOS ONE (2018)
Role of Natural Killer Cells in Airway Inflammation
Ji Heui Kim et al.
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2018)
The Kaleidoscope of Microglial Phenotypes
Marissa L. Dubbelaar et al.
FRONTIERS IN IMMUNOLOGY (2018)
Evaluation of intranasal delivery route of drug administration for brain targeting
Franciska Erdo et al.
BRAIN RESEARCH BULLETIN (2018)
Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
E. Ray Dorsey et al.
LANCET NEUROLOGY (2018)
Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice
Richard Gordon et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Advances in Parkinson's Disease: 200 Years Later
Natalia Lopez-Gonzalez Del Rey et al.
FRONTIERS IN NEUROANATOMY (2018)
Recent Advances in Biomarkers for Parkinson's Disease
Runcheng He et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
A Systematic Review and Meta-Analysis of Alpha Synuclein Auto-Antibodies in Parkinson's Disease
Kirsten M. Scott et al.
FRONTIERS IN NEUROLOGY (2018)
Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease
Jens B. Schroeder et al.
FRONTIERS IN NEUROLOGY (2018)
Autoimmune rheumatic diseases and the risk of Parkinson disease: a nationwide population-based cohort study in Taiwan
Chi-Ching Chang et al.
ANNALS OF MEDICINE (2018)
Modulation of M1/M2 polarization by capsaicin contributes to the survival of dopaminergic neurons in the lipopolysaccharide-lesioned substantia nigra in vivo
Eugene Bok et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
The Effect of Kyolic Aged Garlic Extract on Gut Microbiota, Inflammation, and Cardiovascular Markers in Hypertensives: The GarGIC Trial
Karin Riad et al.
FRONTIERS IN NUTRITION (2018)
Yoga, Meditation and Mind-Body Health: Increased BDNF, Cortisol Awakening Response, and Altered Inflammatory Marker Expression after a 3-Month Yoga and Meditation Retreat
B. Rael Cahn et al.
FRONTIERS IN HUMAN NEUROSCIENCE (2017)
Understanding the functions and relationships of the glymphatic system and meningeal lymphatics
Antoine Louveau et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Treadmill Exercise Prevents Increase of Neuroinflammation Markers Involved in the Dopaminergic Damage of the 6-OHDA Parkinson's Disease Model
Caroline Cristiano Real et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2017)
Analysis of monocyte infiltration in MPTP mice reveals that microglial CX3CR1 protects against neurotoxic over- induction of monocyte- attracting CCL2 by astrocytes
Vincent R. Parillaud et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Mindfulness mediates the physiological markers of stress: Systematic review and meta-analysis
Michaela C. Pascoe et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2017)
Assessment of neuroinflammation in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study
Morten Gersel Stokholm et al.
LANCET NEUROLOGY (2017)
Statins May Facilitate Parkinson's Disease: Insight Gained From a Large, National Claims Database
Guodong Liu et al.
MOVEMENT DISORDERS (2017)
Glitazone Use Associated With Reduced Risk of Parkinson's Disease
Brage Brakedal et al.
MOVEMENT DISORDERS (2017)
Neurotoxic reactive astrocytes are induced by activated microglia
Shane A. Liddelow et al.
NATURE (2017)
Interleukin 4-induced neuroprotection and regulation of microglia activation as a therapeutic approach in the MPTP model of Parkinson's disease
Bjoern Spittau
NEURAL REGENERATION RESEARCH (2017)
Intake of dairy foods and risk of Parkinson disease
Katherine C. Hughes et al.
NEUROLOGY (2017)
Viral hepatitis and Parkinson disease A national record-linkage study
Julia Pakpoor et al.
NEUROLOGY (2017)
TREADMILL EXERCISE PRODUCES NEUROPROTECTIVE EFFECTS IN A MURINE MODEL OF PARKINSON'S DISEASE BY REGULATING THE TLR2/MYD88/NF-κB SIGNALING PATHWAY
Jung-Hoon Koo et al.
NEUROSCIENCE (2017)
Gut microbiota: Implications in Parkinson's disease
Arun Parashar et al.
PARKINSONISM & RELATED DISORDERS (2017)
Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study
Tomomi Minato et al.
PLOS ONE (2017)
Degenerative Joint Diseases and Neuroinflammation
Mariella Fusco et al.
PAIN PRACTICE (2017)
Dextromethorphan Exhibits Anti-inflammatory and Immunomodulatory Effects in a Murine Model of Collagen-Induced Arthritis and in Human Rheumatoid Arthritis
Der-Yuan Chen et al.
SCIENTIFIC REPORTS (2017)
Pathological correlations between traumatic brain injury and chronic neurodegenerative diseases
Marcela Cruz-Haces et al.
TRANSLATIONAL NEURODEGENERATION (2017)
α-Synuclein fibrils recruit peripheral immune cells in the rat brain prior to neurodegeneration
Ashley S. Harms et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Air pollution and Parkinson's disease - evidence and future directions
Natalia Palacios
REVIEWS ON ENVIRONMENTAL HEALTH (2017)
Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson's disease trial
Howard E. Gendelman et al.
NPJ PARKINSONS DISEASE (2017)
Fecal Microbiota Transplantation in Inflammatory Bowel Disease
Walter Reinisch
DIGESTIVE DISEASES (2017)
Midlife milk consumption and substantia nigra neuron density at death
Robert D. Abbott et al.
NEUROLOGY (2016)
Hepatitis C virus infection as a risk factor for Parkinson disease
Hsin-Hsi Tsai et al.
NEUROLOGY (2016)
Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease
Isabel Lastres-Becker et al.
ANTIOXIDANTS & REDOX SIGNALING (2016)
Alterations in Resting-State Functional Connectivity Link Mindfulness Meditation With Reduced Interleukin-6: A Randomized Controlled Trial
J. David Creswell et al.
BIOLOGICAL PSYCHIATRY (2016)
Yogic breathing when compared to attention control reduces the levels of pro-inflammatory biomarkers in saliva: a pilot randomized controlled trial
Waleed O. Twal et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2016)
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease
Timothy R. Sampson et al.
CELL (2016)
Anti-Inflammatory Modulation of Microglia via CD163-Targeted Glucocorticoids Protects Dopaminergic Neurons in the 6-OHDA Parkinson's Disease Model
Noemie Tentillier et al.
JOURNAL OF NEUROSCIENCE (2016)
Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD)
Caroline H. Williams-Gray et al.
MOVEMENT DISORDERS (2016)
Association between hepatitis C virus infection and Parkinson's disease
Jong-Min Kim et al.
MOVEMENT DISORDERS (2016)
A polarizing question: do M1 and M2 microglia exist?
Richard M. Ransohoff
NATURE NEUROSCIENCE (2016)
Advances in markers of prodromal Parkinson disease
Ronald B. Postuma et al.
NATURE REVIEWS NEUROLOGY (2016)
Exenatide and metformin express their anti-inflammatory effects on human monocytes/macrophages by the attenuation of MAPKs and NFκB signaling
Lukasz Buldak et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2016)
Doxycycline Suppresses Microglial Activation by Inhibiting the p38 MAPK and NF-kB Signaling Pathways
Flavia V. Santa-Cecilia et al.
NEUROTOXICITY RESEARCH (2016)
Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms
Valeria D. Felice et al.
PARKINSONISM & RELATED DISORDERS (2016)
Neurodegeneration: From cellular concepts to clinical applications
Alla Katsnelson et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Early Degeneration of Both Dopaminergic and Serotonergic Axons - A Common Mechanism in Parkinson's Disease
Janina Grosch et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2016)
Anti-inflammatory activities of Ganoderma lucidum (Lingzhi) and San-Miao-San supplements in MRL/lpr mice for the treatment of systemic lupus erythematosus
Zhe Cai et al.
CHINESE MEDICINE (2016)
Traumatic Brain Injury Leads to Development of Parkinson's Disease Related Pathology in Mice
Daniela Impellizzeri et al.
FRONTIERS IN NEUROSCIENCE (2016)
Resolvins and omega three polyunsaturated fatty acids: Clinical implications in inflammatory diseases and cancer
Kazuki Moro et al.
WORLD JOURNAL OF CLINICAL CASES (2016)
Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson's disease
Aurelija Jucaite et al.
BRAIN (2015)
Methamphetamine/amphetamine abuse and risk of Parkinson's disease in Utah: A population-based assessment
Karen Curtin et al.
DRUG AND ALCOHOL DEPENDENCE (2015)
Anti-inflammatory Effects of Ganoderma lucidum Triterpenoid in Human Crohn's Disease Associated with Downregulation of NF-κB Signaling
Changda Liu et al.
INFLAMMATORY BOWEL DISEASES (2015)
Striatal blood-brain barrier permeability in Parkinson's disease
Madison T. Gray et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2015)
Intranasal PRGF-Endoret enhances neuronal survival and attenuates NF-κB-dependent inflammation process in a mouse model of Parkinson's disease
Eduardo Anitua et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Silymarin Suppresses Cellular Inflammation By Inducing Reparative Stress Signaling
Erica S. Lovelace et al.
JOURNAL OF NATURAL PRODUCTS (2015)
Lenalidomide reduces microglial activation and behavioral deficits in a transgenic model of Parkinson's disease
Elvira Valera et al.
JOURNAL OF NEUROINFLAMMATION (2015)
Fingolimod induces neuroprotective factors in human astrocytes
Franziska S. Hoffmann et al.
JOURNAL OF NEUROINFLAMMATION (2015)
Selective VIP Receptor Agonists Facilitate Immune Transformation for Dopaminergic Neuroprotection in MPTP-Intoxicated Mice
Katherine E. Olson et al.
JOURNAL OF NEUROSCIENCE (2015)
Tanshinone IIA prevents the loss of nigrostriatal dopaminergic neurons by inhibiting NADPH oxidase and iNOS in the MPTP model of Parkinson's disease
Bo Ren et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)
Hepatitis C virus infection: a risk factor for Parkinson's disease
W. Y. -Y. Wu et al.
JOURNAL OF VIRAL HEPATITIS (2015)
Innate and adaptive immune responses in the CNS
Ari Waisman et al.
LANCET NEUROLOGY (2015)
NINDS Exploratory Trials in Parkinson Disease (NET-PD) FS-ZONE Investigators. Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial. (vol 14, pg 795, 2015)
Chadwick W. Christine
LANCET NEUROLOGY (2015)
Epidemiology of mild traumatic brain injury and neurodegenerative disease
Raquel C. Gardner et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2015)
Statins, Plasma Cholesterol, and Risk of Parkinson's Disease: A Prospective Study
Xuemei Huang et al.
MOVEMENT DISORDERS (2015)
Colonic Bacterial Composition in Parkinson's Disease
Ali Keshavarzian et al.
MOVEMENT DISORDERS (2015)
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Rebecca C. Coll et al.
NATURE MEDICINE (2015)
FK506 reduces neuroinflammation and dopaminergic neurodegeneration in an α-synuclein-based rat model for Parkinson's disease
Anke Van der Perren et al.
NEUROBIOLOGY OF AGING (2015)
NEUROPROTECTIVE EFFECTS OF LIXISENATIDE AND LIRAGLUTIDE IN THE 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MOUSE MODEL OF PARKINSON'S DISEASE
W. Liu et al.
NEUROSCIENCE (2015)
Physical Training Regulates Mitochondrial Parameters and Neuroinflammatory Mechanisms in an Experimental Model of Parkinson's Disease
Talita Tuon et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2015)
Head injury, potential interaction with genes, and risk for Parkinson's disease
Jianjun Gao et al.
PARKINSONISM & RELATED DISORDERS (2015)
Helicobacter pylori infection is associated with worse severity of Parkinson's disease
Ai Huey Tan et al.
PARKINSONISM & RELATED DISORDERS (2015)
Astrocytes in Neurodegenerative Disease
Hemali Phatnani et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2015)
Associations between B Vitamins and Parkinson's Disease
Liang Shen
NUTRIENTS (2015)
Glitazone Treatment and Incidence of Parkinson's Disease among People with Diabetes: A Retrospective Cohort Study
Ruth Brauer et al.
PLOS MEDICINE (2015)
Anti-TNF therapy: past, present and future
Claudia Monaco et al.
INTERNATIONAL IMMUNOLOGY (2015)
Cyclosporine A and MnTMPyP Alleviate α-Synuclein Expression and Aggregation in Cypermethrin-Induced Parkinsonism
Sonal Agrawal et al.
MOLECULAR NEUROBIOLOGY (2015)
Gut Microbiota Are Related to Parkinson's Disease and Clinical Phenotype
Filip Scheperjans et al.
MOVEMENT DISORDERS (2015)
Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial
Tanya Simuni et al.
LANCET NEUROLOGY (2015)
Intensive Rehabilitation Treatment in Early Parkinson's Disease: A Randomized Pilot Study With a 2-Year Follow-up
Giuseppe Frazzitta et al.
NEUROREHABILITATION AND NEURAL REPAIR (2015)
Increased Amoeboid Microglial Density in the Olfactory Bulb of Parkinson's and Alzheimer's Patients
Karlijn J. Doorn et al.
BRAIN PATHOLOGY (2014)
Pioglitazone reduces inflammation through inhibition of NF-κB in polymicrobial sepsis
Jennifer Kaplan et al.
INNATE IMMUNITY (2014)
Yoga's Impact on Inflammation, Mood, and Fatigue in Breast Cancer Survivors: A Randomized Controlled Trial
Janice K. Kiecolt-Glaser et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Effects of cannabidiol in the treatment of patients with Parkinson's disease: An exploratory double-blind trial
Marcos Hortes N. Chagas et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
Gut Feelings About Smoking and Coffee in Parkinson's Disease
Pascal Derkinderen et al.
MOVEMENT DISORDERS (2014)
Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease
Augusta Pisanu et al.
NEUROBIOLOGY OF DISEASE (2014)
Parkinson disease and smoking revisited Ease of quitting is an early sign of the disease
Beate Ritz et al.
NEUROLOGY (2014)
An anti-inflammatory diet as treatment for inflammatory bowel disease: a case series report
Barbara C. Olendzki et al.
NUTRITION JOURNAL (2014)
Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease
Jesus Perez-H et al.
TOXICOLOGY (2014)
Astrocytic modulation of blood brain barrier: perspectives on parkinson's disease
Ricardo Cabezas et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Phenotypic profile of alternative activation marker CD163 is different in Alzheimer's and Parkinson's disease
Peixuan Pey et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
Role of Microglial M1/M2 Polarization in Relapse and Remission of Psychiatric Disorders and Diseases
Yutaka Nakagawa et al.
PHARMACEUTICALS (2014)
The impact of ageing on natural killer cell function and potential consequences for health in older adults
Jon Hazeldine et al.
AGEING RESEARCH REVIEWS (2013)
Alcohol use disorders and risk of Parkinson's disease: findings from a Swedish national cohort study 1972-2008
Anna-Karin Eriksson et al.
BMC NEUROLOGY (2013)
A cohort study on diet and the risk of Parkinson's disease: the role of food groups and diet quality
K. Saaksjarvi et al.
BRITISH JOURNAL OF NUTRITION (2013)
Minocycline: far beyond an antibiotic
N. Garrido-Mesa et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
The Anti-Inflammatory Effects of Acupuncture and Their Relevance to Allergic Rhinitis: A Narrative Review and Proposed Model
John L. McDonald et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)
NK Cells in Central Nervous System Disorders
Aurelie Poli et al.
JOURNAL OF IMMUNOLOGY (2013)
Environmental stress, ageing and glial cell senescence: a novel mechanistic link to Parkinson's disease?
S. J. Chinta et al.
JOURNAL OF INTERNAL MEDICINE (2013)
GM-CSF induces neuroprotective and anti-inflammatory responses in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxicated mice
Lisa M. Kosloski et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Agrochemicals, α-Synuclein, and Parkinson's Disease
Blanca A. Silva et al.
MOLECULAR NEUROBIOLOGY (2013)
Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease
Karin D. van Dijk et al.
MOVEMENT DISORDERS (2013)
Protection of MPTP-induced neuroinflammation and neurodegeneration by Pycnogenol
Mohammad Moshahid Khan et al.
NEUROCHEMISTRY INTERNATIONAL (2013)
Biomarkers in Parkinson's disease (recent update)
Sushil Sharma et al.
NEUROCHEMISTRY INTERNATIONAL (2013)
CNI-1493 Attenuates Neuroinflammation and Dopaminergic Neurodegeneration in the Acute MPTP Mouse Model of Parkinson's Disease
Carmen Noelker et al.
NEURODEGENERATIVE DISEASES (2013)
Discontinuation of statin therapy associates with Parkinson disease A population-based study
Yen-Chieh Lee et al.
NEUROLOGY (2013)
Deep-Brain Stimulation for Parkinson's Disease Reply
Michael S. Okun
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Effect of human interleukin-10 on the expression of nitric oxide synthases in the MPTP-based model of Parkinson's disease
Joanna Schwenkgrub et al.
PHARMACOLOGICAL REPORTS (2013)
Interleukin-1β and tumor necrosis factor-α: reliable targets for protective therapies in Parkinson's Disease?
Maria C. Leal et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2013)
Niacin Modulates Pro-inflammatory Cytokine Secretion. A Potential Mechanism Involved in its Anti-atherosclerotic Effect
Pedro Saul Lipszyc et al.
OPEN CARDIOVASCULAR MEDICINE JOURNAL (2013)
Caffeine Intake, Smoking, and Risk of Parkinson Disease in Men and Women
Rui Liu et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2012)
Meta-Analysis of Early Nonmotor Features and Risk Factors for Parkinson Disease
Alastair J. Noyce et al.
ANNALS OF NEUROLOGY (2012)
Prospective Study of Statin Use and Risk of Parkinson Disease
Xiang Gao et al.
ARCHIVES OF NEUROLOGY (2012)
Fumarate Is Cardioprotective via Activation of the Nrf2 Antioxidant Pathway
Houman Ashrafian et al.
CELL METABOLISM (2012)
Risk of Parkinson Disease Onset in Patients With Diabetes A 9-year population-based cohort study with age and sex stratifications
Yu Sun et al.
DIABETES CARE (2012)
Treatment for Helicobacter pylori infection and risk of parkinson's disease in Denmark
H. H. Nielsen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2012)
Effects of peripheral lymphocyte subpopulations and the clinical correlation with Parkinson's disease
Fumitoshi Niwa et al.
GERIATRICS & GERONTOLOGY INTERNATIONAL (2012)
CNS infections, sepsis and risk of Parkinson's disease
Fang Fang et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2012)
Innate immunity in the central nervous system
Richard M. Ransohoff et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Human NK Cells Induce Neutrophil Apoptosis via an NKp46-and Fas-Dependent Mechanism
Fredrik B. Thoren et al.
JOURNAL OF IMMUNOLOGY (2012)
CD4+Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson's Disease
Jessica A. Hutter Saunders et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)
Naloxone inhibits immune cell function by suppressing superoxide production through a direct interaction with gp91phox subunit of NADPH oxidase
Qingshan Wang et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Head injury and Parkinson's disease: A population-based study
Fang Fang et al.
MOVEMENT DISORDERS (2012)
Granulocyte macrophage colony-stimulating factor treatment of a patient in myasthenic crisis: Effects on regulatory T cells
Julie Rowin et al.
MUSCLE & NERVE (2012)
Habitual intake of dietary flavonoids and risk of Parkinson disease
X. Gao et al.
NEUROLOGY (2012)
Chronic inflammatory diseases are stimulated by current lifestyle: how diet, stress levels and medication prevent our body from recovering
Margarethe M. Bosma-den Boer et al.
NUTRITION & METABOLISM (2012)
Diagnosis of Parkinson's Disease Based on Disease-Specific Autoantibody Profiles in Human Sera
Min Han et al.
PLOS ONE (2012)
Genetics of Parkinson's Disease
Christine Klein et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Evolving role of 2B4/CD244 in T and NK cell responses during virus infection
Stephen N. Waggoner et al.
FRONTIERS IN IMMUNOLOGY (2012)
Deep-Brain Stimulation for Parkinson's Disease
Michael S. Okun
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Inflammation after Trauma: Microglial Activation and Traumatic Brain Injury
Anil F. Ramlackhansingh et al.
ANNALS OF NEUROLOGY (2011)
Does late onset depression predispose to dementia? A retrospective, case-controlled study
Irit Ohanna et al.
COMPREHENSIVE PSYCHIATRY (2011)
Rotenone, Paraquat, and Parkinson's Disease
Caroline M. Tanner et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2011)
NSAID use and risk of Parkinson disease: a population-based case-control study
C. Becker et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Ganoderma lucidum Protects Dopaminergic Neuron Degeneration through Inhibition of Microglial Activation
Ruiping Zhang et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2011)
Neuroprotection by the selective iNOS inhibitor GW274150 in a model of Parkinson disease
Lauren Broom et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Curcumin: An Anti-Inflammatory Molecule from a Curry Spice on the Path to Cancer Treatment
Purusotam Basnet et al.
MOLECULES (2011)
Granulocyte macrophage-colony stimulating factor protects against substantia nigra dopaminergic cell loss in an environmental toxin model of Parkinson's disease
E. N. Mangano et al.
NEUROBIOLOGY OF DISEASE (2011)
Use of ibuprofen and risk of Parkinson disease
Xiang Gao et al.
NEUROLOGY (2011)
ROSIGLITAZONE DECREASES PEROXISOME PROLIFERATOR RECEPTOR-GAMMA LEVELS IN MICROGLIA AND INHIBITS TNF-ALPHA PRODUCTION: NEW EVIDENCES ON NEUROPROTECTION IN A PROGRESSIVE PARKINSON'S DISEASE MODEL
A. R. Carta et al.
NEUROSCIENCE (2011)
α-Synuclein Reactive Antibodies as Diagnostic Biomarkers in Blood Sera of Parkinson's Disease Patients
Kiran Yanamandra et al.
PLOS ONE (2011)
IFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease
C. Barcia et al.
CELL DEATH & DISEASE (2011)
Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease
Mohd. Moshahid Khan et al.
BRAIN RESEARCH (2010)
Novel Insights into the Cellular Mechanisms of the Anti-inflammatory Effects of NF-κB Essential Modulator Binding Domain Peptides
Eric T. Baima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Calcium Channel Blocker Use and Risk of Parkinson's Disease
Kelly Claire Simon et al.
MOVEMENT DISORDERS (2010)
Incidence of Parkinson's Disease Among Hospital Patients with Methamphetamine-Use Disorders
Russell C. Callaghan et al.
MOVEMENT DISORDERS (2010)
Molecular Profiling of a 6-Hydroxydopamine Model of Parkinson's Disease
Sang J. Na et al.
NEUROCHEMICAL RESEARCH (2010)
Anti-inflammatory Activity of Salvianolic Acid B in Microglia Contributes to its Neuroprotective Effect
Shao-Xia Wang et al.
NEUROCHEMICAL RESEARCH (2010)
Relationship between Blood Levels of Heavy Metals and Parkinson's Disease in China
Tetsuhito Fukushima et al.
NEUROEPIDEMIOLOGY (2010)
Physical activities and future risk of Parkinson disease
Q. Xu et al.
NEUROLOGY (2010)
Smoking duration, intensity, and risk of Parkinson disease
H. Chen et al.
NEUROLOGY (2010)
Inflammation in Neurological Disorders: A Help or a Hindrance?
V. Wee Yong
NEUROSCIENTIST (2010)
Microglia Acquire Distinct Activation Profiles Depending on the Degree of α-Synuclein Neuropathology in a rAAV Based Model of Parkinson's Disease
Vanesa Sanchez-Guajardo et al.
PLOS ONE (2010)
Effect of prolonged exposure to diesel engine exhaust on proinflammatory markers in different regions of the rat brain
Miriam E. Gerlofs-Nijland et al.
PARTICLE AND FIBRE TOXICOLOGY (2010)
Anti-inflammatory activities of essential oils and their constituents from different provenances of indigenous cinnamon (Cinnamomum osmophloeum) leaves
Yu-Tang Tung et al.
PHARMACEUTICAL BIOLOGY (2010)
Anti-inflammatory effects of the Mediterranean diet: the experience of the PREDIMED study
Ramon Estruch
PROCEEDINGS OF THE NUTRITION SOCIETY (2010)
T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?
Stanley H. Appel et al.
TRENDS IN IMMUNOLOGY (2010)
Resveratrol attenuates oxidative stress and improves behaviour in 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine (MPTP) challenged mice
Annadurai Anandhan et al.
ANNALS OF NEUROSCIENCES (2010)
Plasma Urate and Parkinson's Disease in the Atherosclerosis Risk in Communities (ARIC) Study
Honglei Chen et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2009)
Parkinson's Disease and Residential Exposure to Maneb and Paraquat From Agricultural Applications in the Central Valley of California
Sadie Costello et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2009)
Minocycline and neurodegenerative diseases
Hye-Sun Kim et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease
Nicoletta Schintu et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
Olfactory dysfunction as a diagnostic marker for Parkinson's disease
Antje Haehner et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2009)
Cannabinoids as novel anti-inflammatory drugs
Prakash Nagarkatti et al.
FUTURE MEDICINAL CHEMISTRY (2009)
The anti-inflammatory pharmacology of Pycnogenol® in humans involves COX-2 and 5-LOX mRNA expression in leukocytes
Raffaella Canali et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2009)
Intrastriatal Lipopolysaccharide Injection Induces Parkinsonism in C57/B6 Mice
Randy L. Hunter et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2009)
INTERFERON-γ DEFICIENCY MODIFIES THE MOTOR AND CO-MORBID BEHAVIORAL PATHOLOGY AND NEUROCHEMICAL CHANGES PROVOKED BY THE PESTICIDE PARAQUAT
D. Litteljohn et al.
NEUROSCIENCE (2009)
Neuroprotective Effects of the Triterpenoid, CDDO Methyl Amide, a Potent Inducer of Nrf2-Mediated Transcription
Lichuan Yang et al.
PLOS ONE (2009)
Neuropathology of non-motor features of Parkinson disease
Dennis W. Dickson et al.
PARKINSONISM & RELATED DISORDERS (2009)
Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration
Haeman Jang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Prospective Cohort Study of Type 2 Diabetes and the Risk of Parkinson's Disease
Jane A. Driver et al.
DIABETES CARE (2008)
Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats
Feng Jin et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Rheumatoid arthritis accompanied by Parkinson disease
Toshiaki Kogure et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2008)
Neuroinflammation mediated by IL-1β increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease
James B. Koprich et al.
JOURNAL OF NEUROINFLAMMATION (2008)
Parkinson's disease: clinical features and diagnosis
J. Jankovic
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Intranigral lentiviral delivery of dominant-negative TNF attenuates neurodegeneration and behavioral deficits in hemiparkinsonian rats
Melissa K. McCoy et al.
MOLECULAR THERAPY (2008)
Effect of resistance training on blood oxidative stress in Parkinson disease
Richard J. Bloomer et al.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2008)
Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFα, and INFγ concentrations are elevated in patients with atypical and idiopathic parkinsonism
Bogdan Brodacki et al.
NEUROSCIENCE LETTERS (2008)
Inhaled ultrafine particulate matter affects CNS inflammatory processes and may act via MAP kinase signaling pathways
M. T. Kleinman et al.
TOXICOLOGY LETTERS (2008)
Genomic and nongenomic effects of glucocorticoids
Cindy Stahn et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2008)
Differential effects of black versus green tea on risk of Parkinson's disease in the Singapore Chinese Health Study
Louis C. Tan et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Multiple proteins implicated in neurodegenerative diseases accumulate in axons after brain trauma in humans
Kunihiro Uryu et al.
EXPERIMENTAL NEUROLOGY (2007)
Selective inhibition of NF-κB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease
Anamitra Ghosh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease
Angelika D. Wahner et al.
NEUROLOGY (2007)
Neuroinflammatory mechanisms in Parkinson's disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention
Malu G. Tansey et al.
EXPERIMENTAL NEUROLOGY (2007)
Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease
Ashley D. Reynolds et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Prospective study of dietary pattern and risk of Parkinson disease
Xiang Gao et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2007)
Plasma urate and risk of Parkinson's disease
M. G. Weisskopf et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Neuroinflammation in Parkinson's patients and MPTP-treated mice is not restricted to the nigrostriatal system:: Microgliosis and differential expression of interleukin-1 receptors in the olfactory bulb
Anne Vroon et al.
EXPERIMENTAL GERONTOLOGY (2007)
Rifaximin is a gut-specific human pregnane X receptor activator
Xiaochao Ma et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Non-steroidal anti-inflammatory drugs in Parkinson's disease
Ennio Esposito et al.
EXPERIMENTAL NEUROLOGY (2007)
Consumption of dairy products and risk of Parkinson's disease
Honglei Chen et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
TNF-α knockout and minocycline treatment attenuates blood-brain barrier leakage in MPTP-treated mice
Chaohui Zhao et al.
NEUROBIOLOGY OF DISEASE (2007)
Type 2 diabetes and the risk of Parkinson's disease
Gang Hu et al.
DIABETES CARE (2007)
Temporal relationship between cigarette smoking and risk of Parkinson disease
E. L. Thacker et al.
NEUROLOGY (2007)
Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease
Dana B. Hancock et al.
ARCHIVES OF NEUROLOGY (2007)
Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease
Melissa K. McCoy et al.
JOURNAL OF NEUROSCIENCE (2006)
Malignant melanoma and other types of cancer preceding Parkinson disease
Jorgen H. Olsen et al.
EPIDEMIOLOGY (2006)
The effects of diet on inflammation - Emphasis on the metabolic syndrome
Dario Giugliano et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Natural killer cells as an initial defense against pathogens
Melissa B. Lodoen et al.
CURRENT OPINION IN IMMUNOLOGY (2006)
Head injury and Parkinson's disease risk in twins
Samuel M. Goldman et al.
ANNALS OF NEUROLOGY (2006)
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
A Gerhard et al.
NEUROBIOLOGY OF DISEASE (2006)
NSAID Use and the Risk of Parkinson's Disease
Mahyar Etminan et al.
CURRENT DRUG SAFETY (2006)
A possible role for humoral immunity in the pathogenesis of Parkinson's disease
CF Orr et al.
BRAIN (2005)
Garlic increases IL-10 and inhibits TNFα and IL-6 production in endotoxin-stimulated human placental explants
A Makris et al.
PLACENTA (2005)
6-Hydroxydopamine-induced alterations in blood-brain barrier permeability
PM Carvey et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
NK-dependent DC maturation is mediated by TNFα and IFNγ released upon engagement of the NKp30 triggering receptor
M Vitale et al.
BLOOD (2005)
GW274150 and GW273629 are potent and highly selective inhibitors of inducible nitric oxide synthase in vitro and in vivo
WK Alderton et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
ATP mediates rapid microglial response to local brain injury in vivo
D Davalos et al.
NATURE NEUROSCIENCE (2005)
Aggregated α-synuclein activates microglia:: a process leading to disease progression in Parkinson's disease
W Zhang et al.
FASEB JOURNAL (2005)
Anti-inflammatory roles of retinoic acid in rat brain astrocytes:: Suppression of interferon-γ-induced JAK/STAT phosphorylation
WH Choi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Physical activity and the risk of Parkinson disease
H Chen et al.
NEUROLOGY (2005)
Blood-brain barrier dysfunction in Parkinsonian midbrain in vivo
R Kortekaas et al.
ANNALS OF NEUROLOGY (2005)
Particulate matter in polluted air may increase biomarkers of inflammation in mouse brain
A Campbell et al.
NEUROTOXICOLOGY (2005)
Alterations of T-lymphocyte populations in Parkinson disease
Y Baba et al.
PARKINSONISM & RELATED DISORDERS (2005)
Inflammatory process as a determinant factor for the degeneration of substantia nigra dopaminergic neurons
AJ Herrera et al.
JOURNAL OF NEURAL TRANSMISSION (2005)
Drug therapy: Thiazolidinediones
H Yki-Jarvinen
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming
A Martín-Fontecha et al.
NATURE IMMUNOLOGY (2004)
Neuroprotective effects of nonsteroidal anti-inflammatory drugs on neurodegenerative diseases
M Asanuma et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Coffee consumption, gender, and Parkinson's disease mortality in the Cancer Prevention Study II cohort: The modifying effects of estrogen
A Ascherio et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease
EJ Benner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation
T Dehmer et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease
I Kurkowska-Jastrzebska et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2004)
The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2
SW Paugh et al.
FEBS LETTERS (2003)
Inactivation of TNF signaling by rationally designed dominant-negative TNF variants
PM Steed et al.
SCIENCE (2003)
Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease
HL Chen et al.
ARCHIVES OF NEUROLOGY (2003)
Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: Role of neuroinflammation
B Liu et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2003)
Dietary intakes of fat and risk of Parkinson's disease
H Chen et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)
Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation
YX Liu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
A cross-cultural study: anti-inflammatory activity of Australian and Chinese plants
RW Li et al.
JOURNAL OF ETHNOPHARMACOLOGY (2003)
Capsaicin exhibits anti-inflammatory property by inhibiting IkB-a degradation in LPS-stimulated peritoneal macrophages
CS Kim et al.
CELLULAR SIGNALLING (2003)
Potential functional foods in the traditional Maori diet
RC Cambie et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2003)
Activation of microglia by human neuromelanin is NF-kappa B-dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson's disease
H Wilms et al.
FASEB JOURNAL (2003)
Stress and the inflammatory response: A review of neurogenic inflammation
PH Black
BRAIN BEHAVIOR AND IMMUNITY (2002)
Cytokines and neuro-immune-endocrine interactions:: a role for the hypothalamic-pituitary-adrenal revolving axis
JJ Haddad et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Plantation work and risk of Parkinson disease in a population-based longitudinal study
H Petrovitch et al.
ARCHIVES OF NEUROLOGY (2002)
Juvenile parkinsonism as a manifestation of systemic lupus erythematosus:: Case report and review of the literature
JM García-Moreno et al.
MOVEMENT DISORDERS (2002)
Protective action of the peroxisome proliferator-activated receptor-γ agonist pioglitazone in a mouse model of Parkinson's disease
T Breidert et al.
JOURNAL OF NEUROCHEMISTRY (2002)
The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh-TNF-α, IL-1β and IFN-γ
A Castaño et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons
HM Gao et al.
JOURNAL OF NEUROSCIENCE (2002)
Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration
MM Iravani et al.
NEUROSCIENCE (2002)
Cigarette smoking and the incidence of Parkinson's disease in two prospective studies
MA Hernán et al.
ANNALS OF NEUROLOGY (2001)
Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum
Y He et al.
BRAIN RESEARCH (2001)
Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism
J Bas et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
Smoking, alcohol, and coffee consumption preceding Parkinson's disease - A case-control study
MD Benedetti et al.
NEUROLOGY (2000)
Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity
KP Mohanakumar et al.
BRAIN RESEARCH (2000)
分享论文
